{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:51:16Z","timestamp":1782215476546,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02165-5","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:43:31Z","timestamp":1777574611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-103a-3p contributes to diabetic retinopathy progression via suppressing MFN2"],"prefix":"10.1186","volume":"18","author":[{"given":"Yidan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"6","key":"2165_CR1","doi-asserted-by":"publisher","first-page":"e201023222418","DOI":"10.2174\/0115733998253672231011161400","volume":"20","author":"V Kour","year":"2024","unstructured":"Kour V, Swain J, Singh J, Singh H, Kour H. A Review on Diabetic Retinopathy. Curr Diabetes Rev. 2024;20(6):e201023222418.","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"2165_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12886-023-03118-6","volume":"23","author":"H Li","year":"2023","unstructured":"Li H, Liu X, Zhong H, Fang J, Li X, Shi R, et al. Research progress on the pathogenesis of diabetic retinopathy. BMC Ophthalmol. 2023;23(1):372.","journal-title":"BMC Ophthalmol"},{"key":"2165_CR3","doi-asserted-by":"publisher","first-page":"e18308","DOI":"10.7717\/peerj.18308","volume":"12","author":"H Basir","year":"2024","unstructured":"Basir H, Nugrahani ASD, Aman AM, Bakri S, Rasyid H, Umar H, et al. The association between fibroblast growth factor 21 with diabetes retinopathy among type 2 diabetes mellitus patients: a systematic review, meta-analysis, and meta-regression. PeerJ. 2024;12:e18308.","journal-title":"PeerJ"},{"key":"2165_CR4","first-page":"e280323215026","volume":"17","author":"P Chandra","year":"2024","unstructured":"Chandra P, Sachan N, Saraswat N, Vyawahare N. A Detailed Review of Molecular Pathways and Mechanisms Responsible for the Development and Aggravation of Neuropathy and Nephropathy in Diabetes. Curr Mol Pharmacol. 2024;17:e280323215026.","journal-title":"Curr Mol Pharmacol"},{"issue":"10","key":"2165_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14712598.2023.2247987","volume":"23","author":"A Shughoury","year":"2023","unstructured":"Shughoury A, Bhatwadekar A, Jusufbegovic D, Hajrasouliha A, Ciulla TA. The evolving therapeutic landscape of diabetic retinopathy. Expert Opin Biol Ther. 2023;23(10):969\u201385.","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"2165_CR6","first-page":"164","volume":"10","author":"Y Xu","year":"2021","unstructured":"Xu Y, Huang X, Luo Q, Zhang X. MicroRNAs Involved in Oxidative Stress Processes Regulating Physiological and Pathological Responses. MicroRNA (Shariqah United Arab Emirates). 2021;10(3):164\u201380.","journal-title":"MicroRNA (Shariqah United Arab Emirates)"},{"issue":"3","key":"2165_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12291-021-01018-4","volume":"37","author":"P Sadashiv, Sharma","year":"2022","unstructured":"Sadashiv, Sharma P, Dwivedi S, Tiwari S, Singh PK, Pal A, et al. Micro (mi) RNA and Diabetic Retinopathy. Indian J Clin biochemistry: IJCB. 2022;37(3):267\u201374.","journal-title":"Indian J Clin biochemistry: IJCB"},{"issue":"11","key":"2165_CR8","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1210\/clinem\/dgaa538","volume":"105","author":"Y Yang","year":"2020","unstructured":"Yang Y, Liu Y, Li Y, Chen Z, Xiong Y, Zhou T, et al. MicroRNA-15b Targets VEGF and Inhibits Angiogenesis in Proliferative Diabetic Retinopathy. J Clin Endocrinol Metab. 2020;105(11):3404\u201315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2165_CR9","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/02713683.2022.2039206","volume":"47","author":"J Cao","year":"2022","unstructured":"Cao J, Zhao C, Gong L, Cheng X, Yang J, Zhu M, et al. MiR-181 Enhances Proliferative and Migratory Potentials of Retinal Endothelial Cells in Diabetic Retinopathy by Targeting KLF6. Curr Eye Res. 2022;47(6):882\u20138.","journal-title":"Curr Eye Res"},{"key":"2165_CR10","doi-asserted-by":"crossref","unstructured":"Kot A, Kaczmarek R. Exosomal miRNA Profiling in Vitreous Humor in Proliferative Diabetic Retinopathy. Cells. 2022;12(1):123.","DOI":"10.3390\/cells12010123"},{"issue":"6","key":"2165_CR11","doi-asserted-by":"publisher","first-page":"e70031","DOI":"10.1111\/acel.70031","volume":"24","author":"L Wu","year":"2025","unstructured":"Wu L, Zhu X, Pan S, Chen Y, Luo C, Zhao Y, et al. Diabetes Advances Cardiomyocyte Senescence Through Interfering Rnd3 Expression and Function. Aging Cell. 2025;24(6):e70031.","journal-title":"Aging Cell"},{"issue":"11","key":"2165_CR12","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1002\/jcp.30878","volume":"237","author":"Y Wu","year":"2022","unstructured":"Wu Y, Lan H, Zhang D, Hu Z, Zhang J, Li Z, et al. Research progress on ncRNAs regulation of mitochondrial dynamics in diabetes. J Cell Physiol. 2022;237(11):4112\u201331.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2165_CR13","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/s41467-025-56673-5","volume":"16","author":"M Joaquim","year":"2025","unstructured":"Joaquim M, Altin S, Bulimaga MB, Sim\u00f5es T, Nolte H, Bader V, et al. Mitofusin 2 displays fusion-independent roles in proteostasis surveillance. Nat Commun. 2025;16(1):1501.","journal-title":"Nat Commun"},{"issue":"6","key":"2165_CR14","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1002\/mco2.462","volume":"4","author":"Y Wang","year":"2023","unstructured":"Wang Y, Dai X, Li H, Jiang H, Zhou J, Zhang S, et al. The role of mitochondrial dynamics in disease. MedComm. 2023;4(6):e462.","journal-title":"MedComm"},{"key":"2165_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2017.05.009","volume":"452","author":"R Zhang","year":"2017","unstructured":"Zhang R, Garrett Q, Zhou H, Wu X, Mao Y, Cui X, et al. Upregulation of miR-195 accelerates oxidative stress-induced retinal endothelial cell injury by targeting mitofusin 2 in diabetic rats. Mol Cell Endocrinol. 2017;452:33\u201343.","journal-title":"Mol Cell Endocrinol"},{"key":"2165_CR16","doi-asserted-by":"publisher","first-page":"e180823219999","DOI":"10.2174\/1874467217666230818113538","volume":"17","author":"M Yeganeh-Hajahmadi","year":"2024","unstructured":"Yeganeh-Hajahmadi M, Moosavi-Saeed Y, Rostamzadeh F. Apelin Receptor Dimerization and Oligomerization. Curr Mol Pharmacol. 2024;17:e180823219999.","journal-title":"Curr Mol Pharmacol"},{"issue":"Suppl 1","key":"2165_CR17","first-page":"S20","volume":"47","author":"2","year":"2024","unstructured":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20\u201342.","journal-title":"Diabetes Care"},{"key":"2165_CR18","doi-asserted-by":"publisher","first-page":"113908","DOI":"10.1016\/j.bcp.2020.113908","volume":"175","author":"CBM Platania","year":"2020","unstructured":"Platania CBM, Pittal\u00e0 V, Pascale A, Marchesi N, Anfuso CD, Lupo G, et al. Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells. Biochem Pharmacol. 2020;175:113908.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2165_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00125-015-3832-0","volume":"59","author":"S Zhao","year":"2016","unstructured":"Zhao S, Li T, Li J, Lu Q, Han C, Wang N, et al. miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway. Diabetologia. 2016;59(3):644\u201354.","journal-title":"Diabetologia"},{"issue":"1","key":"2165_CR20","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1038\/s41598-021-88698-3","volume":"11","author":"K Becker","year":"2021","unstructured":"Becker K, Klein H, Simon E, Viollet C, Haslinger C, Leparc G, et al. In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathy. Sci Rep. 2021;11(1):10494.","journal-title":"Sci Rep"},{"issue":"11","key":"2165_CR21","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.4103\/1673-5374.259602","volume":"14","author":"B Martinez","year":"2019","unstructured":"Martinez B, Peplow PV. MicroRNAs as biomarkers of diabetic retinopathy and disease progression. Neural regeneration Res. 2019;14(11):1858\u201369.","journal-title":"Neural regeneration Res"},{"issue":"7","key":"2165_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s00592-023-02077-0","volume":"60","author":"W Liu","year":"2023","unstructured":"Liu W, Luo Z, Zhang L, Wang Y, Yang J, You D, et al. hsa-mir-(4328, 4422, 548z and \u2013\u2009628-5p) in diabetic retinopathy: diagnosis, prediction and linking a new therapeutic target. Acta Diabetol. 2023;60(7):929\u201342.","journal-title":"Acta Diabetol"},{"key":"2165_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cca.2019.10.036","volume":"501","author":"H Ji","year":"2020","unstructured":"Ji H, Yi Q, Chen L, Wong L, Liu Y, Xu G, et al. Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy. Clin Chim Acta. 2020;501:147\u201353.","journal-title":"Clin Chim Acta"},{"key":"2165_CR24","doi-asserted-by":"publisher","first-page":"941982","DOI":"10.3389\/fimmu.2022.941982","volume":"13","author":"X Zhao","year":"2022","unstructured":"Zhao X, Ling F, Zhang GW, Yu N, Yang J, Xin XY. The Correlation Between MicroRNAs and Diabetic Retinopathy. Front Immunol. 2022;13:941982.","journal-title":"Front Immunol"},{"key":"2165_CR25","doi-asserted-by":"publisher","first-page":"960327122109958","DOI":"10.1177\/09603271221099589","volume":"41","author":"W Li","year":"2022","unstructured":"Li W, Yang S, Chen G, He S. MiR-200c-3p regulates pyroptosis by targeting SLC30A7 in diabetic retinopathy. Hum Exp Toxicol. 2022;41:9603271221099589.","journal-title":"Hum Exp Toxicol"},{"key":"2165_CR26","doi-asserted-by":"publisher","first-page":"110314","DOI":"10.1016\/j.exer.2025.110314","volume":"254","author":"M An","year":"2025","unstructured":"An M, Huang J, Zhao J, Wang L, Liu Y. PDZK1 regulated by miR-145-5p protects against endothelial cell apoptosis and diabetic retinopathy by targeting mitochondrial function. Exp Eye Res. 2025;254:110314.","journal-title":"Exp Eye Res"},{"key":"2165_CR27","doi-asserted-by":"publisher","first-page":"858286","DOI":"10.3389\/fcell.2022.858286","volume":"10","author":"M Zaman","year":"2022","unstructured":"Zaman M, Shutt TE. The Role of Impaired Mitochondrial Dynamics in MFN2-Mediated Pathology. Front cell Dev biology. 2022;10:858286.","journal-title":"Front cell Dev biology"},{"issue":"5","key":"2165_CR28","doi-asserted-by":"publisher","first-page":"809","DOI":"10.7150\/ijms.94485","volume":"21","author":"T Wang","year":"2024","unstructured":"Wang T, Xing G, Fu T, Ma Y, Wang Q, Zhang S, et al. Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies. Int J Med Sci. 2024;21(5):809\u201316.","journal-title":"Int J Med Sci"},{"key":"2165_CR29","doi-asserted-by":"crossref","unstructured":"Huang CP, Lin YW, Huang YC, Tsai FJ. Mitochondrial Dysfunction as a Novel Target for Neuroprotective Nutraceuticals in Ocular Diseases. Nutrients. 2020;12(7):1950.","DOI":"10.3390\/nu12071950"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02165-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02165-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02165-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:16:56Z","timestamp":1782213416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02165-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2165"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02165-5","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they have obtained Daping Hospital, Army Medical University review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}